Diebold Nixdorf
Market Cap
US$729.1m
Last Updated
2019/10/22 23:34 UTC
Data Sources
Company Financials +
Executive Summary
Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America.
Snowflake
Fundamentals
Slightly overvalued with imperfect balance sheet.
Similar Companies
Share Price & News
How has Diebold Nixdorf's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
0.8%
DBD
1.9%
US Tech
0.07%
US Market
1 Year Return
150.0%
DBD
7.3%
US Tech
8.9%
US Market
Return vs Industry: DBD exceeded the US Tech industry which returned 7.3% over the past year.
Return vs Market: DBD exceeded the US Market which returned 8.9% over the past year.
Shareholder returns
| DBD | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.8% | 1.9% | 0.07% |
| 30 Day | -22.9% | 9.4% | -0.3% |
| 90 Day | -7.7% | 13.8% | -1.6% |
| 1 Year | 150.0%150.0% | 9.1%7.3% | 11.3%8.9% |
| 3 Year | -55.0%-56.3% | 103.0%87.4% | 46.3%36.8% |
| 5 Year | -72.1%-74.9% | 121.8%99.2% | 62.1%44.3% |
Price Volatility Vs. Market
How volatile is Diebold Nixdorf's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
The Diebold Nixdorf (NYSE:DBD) Share Price Is Up 152% And Shareholders Are Boasting About It1 month ago | Simply Wall St
Diebold Nixdorf (NYSE:DBD) Has A Somewhat Strained Balance SheetValuation
Is Diebold Nixdorf undervalued compared to its fair value and its price relative to the market?
>50%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: DBD ($9.5) is trading below our estimate of fair value ($39.19)
Significantly Below Fair Value: DBD is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: DBD is unprofitable, so we can't compare its PE Ratio to the Tech industry average.
PE vs Market: DBD is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate DBD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: DBD has negative assets, so we can't compare its PB Ratio to the US Tech industry average.
Next Steps
Future Growth
How is Diebold Nixdorf forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
81.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DBD is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: DBD is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: DBD is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: DBD's revenue (1.4% per year) is forecast to grow slower than the US market (7.2% per year).
High Growth Revenue: DBD's revenue (1.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DBD's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Diebold Nixdorf performed over the past 5 years?
-65.6%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: DBD is unprofitable, and losses have increased over the past 5 years at a rate of -65.6% per year.
Accelerating Growth: Unable to compare DBD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DBD is unprofitable, making it difficult to compare its past year earnings growth to the Tech industry (64%).
Return on Equity
High ROE: DBD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
ROA vs Industry: DBD is currently unprofitable, so its Return on Assets is negative.
Return on Capital Employed
ROCE Improving: DBD is currently unprofitable, so its Return on Capital Employed is negative.
Next Steps
Financial Health
How is Diebold Nixdorf's financial position?
Financial Position Analysis
Short Term Liabilities: DBD has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: DBD has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: DBD has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: DBD's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Inventory Level: DBD has a high level of physical assets or inventory.
Debt Coverage by Assets: DBD has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable DBD has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: DBD is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -16.5% per year.
Next Steps
Dividend
What is Diebold Nixdorf's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate DBD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate DBD's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if DBD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DBD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: DBD is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of DBD's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of Diebold Nixdorf's salary, the management and board of directors tenure and is there insider trading?
2.7yrs
Average management tenure
CEO
Gerrard Schmid (50yo)
1.7yrs
Tenure
US$7,036,314
Compensation
Mr. Gerrard B. Schmid has been President and Chief executive Officer of Diebold Nixdorf, Incorporated since February 2018 and has been its Director since February 21, 2018. Mr. Schmid served as Chief Execu ...
CEO Compensation Analysis
Compensation vs. Market: Gerrard has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Gerrard's compensation with company performance.
Management Age and Tenure
2.7yrs
Average Tenure
52yo
Average Age
Experienced Management: DBD's management team is considered experienced (2.7 years average tenure).
Board Age and Tenure
1.7yrs
Average Tenure
60.5yo
Average Age
Experienced Board: DBD's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: DBD insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Shares | 9,615 |
| Max Price | US$10.40 |
| Entity | Company |
| Shares | 2,000 |
| Max Price | US$13.70 |
| Entity | Company |
| Shares | 290,680 |
| Max Price | US$14.42 |
| Entity | Company |
| Shares | 26,800 |
| Max Price | US$9.58 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 6,000 |
| Max Price | US$14.05 |
| Entity | Individual |
| Role | Chairman of the Board Non-Executive Chairman |
| Shares | 5,000 |
| Max Price | US$9.13 |
| Entity | Individual |
| Role | Chairman of the Board Non-Executive Chairman |
| Shares | 5,000 |
| Max Price | US$9.44 |
| Entity | Individual |
| Role | Chief Financial Officer Senior VP & CFO |
| Shares | 10,000 |
| Max Price | US$9.12 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 3,000 |
| Max Price | US$9.05 |
| Entity | Individual |
| Role | Senior Key Executive Senior Vice President of Services |
| Shares | 20,000 |
| Max Price | US$9.18 |
| Entity | Individual |
| Shares | 25,000 |
| Max Price | US$9.01 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 2,500 |
| Max Price | US$10.99 |
| Entity | Individual |
| Role | Chief Financial Officer Senior VP & CFO |
| Shares | 19,100 |
| Max Price | US$10.54 |
| Entity | Individual |
| Role | Senior Key Executive Senior Vice President of Products |
| Shares | 10,000 |
| Max Price | US$10.21 |
| Entity | Individual |
| Role | Senior Key Executive Senior Vice President of Products |
| Shares | 10,000 |
| Max Price | US$10.06 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 2,500 |
| Max Price | US$10.11 |
| Entity | Individual |
| Role | Chief Executive Officer President |
| Shares | 22,222 |
| Max Price | US$8.80 |
| Entity | Individual |
| Role | Senior Key Executive Senior Vice President of Services |
| Shares | 21,000 |
| Max Price | US$9.07 |
| Entity | Individual |
| Role | Senior Key Executive Senior Vice President of Products |
| Shares | 26,000 |
| Max Price | US$8.57 |
| Entity | Company |
| Shares | 28,000 |
| Max Price | US$5.10 |
| Entity | Company |
| Shares | 8,000 |
| Max Price | US$7.32 |
| Entity | Company |
| Shares | 11,000 |
| Max Price | US$7.57 |
| Entity | Company |
| Shares | 801,948 |
| Max Price | US$8.46 |
| Entity | Company |
| Shares | 570,271 |
| Max Price | US$8.61 |
| Entity | Company |
| Shares | 10,000 |
| Max Price | US$2.45 |
| Entity | Individual |
| Shares | 24,000 |
| Max Price | US$4.23 |
| Entity | Individual |
| Shares | 23,498 |
| Max Price | US$4.65 |
| Entity | Company |
| Shares | 957,402 |
| Max Price | US$4.05 |
| Entity | Company |
| Shares | 207,300 |
| Max Price | US$4.00 |
| Entity | Individual |
| Shares | 7,400 |
| Max Price | US$2.94 |
| Entity | Company |
| Shares | 9,000 |
| Max Price | US$3.42 |
| Entity | Individual |
| Shares | 3,000 |
| Max Price | US$3.22 |
| Entity | Company |
| Shares | 25,500 |
| Max Price | US$2.62 |
| Entity | Company |
| Shares | 7,400 |
| Max Price | US$3.90 |
| Entity | Company |
| Shares | 1,454,790 |
| Max Price | US$4.76 |
| Entity | Company |
| Shares | 39,201 |
| Max Price | US$4.81 |
| Entity | Company |
| Shares | 16,000 |
| Max Price | US$4.43 |
| Entity | Company |
| Shares | 108,701 |
| Max Price | US$4.35 |
| Entity | Company |
| Shares | 760,332 |
| Max Price | US$4.81 |
| Entity | Company |
| Shares | 732,455 |
| Max Price | US$4.79 |
| Entity | Individual |
| Shares | 15,898 |
| Max Price | US$4.83 |
| Entity | Individual |
| Shares | 14,898 |
| Max Price | US$4.83 |
| Entity | Company |
| Shares | 15,000 |
| Max Price | US$4.02 |
Ownership Breakdown
Management Team
Jeff Rutherford (58yo)
Senior VP & CFO
- Tenure: 1yrs
- Compensation: US$825.00k
Gerrard Schmid (50yo)
President
- Tenure: 1.7yrs
- Compensation: US$7.04m
Mike Jacobsen
Senior Director of Corporate Communications
- Tenure: 0yrs
Devon Watson
VP & Chief Marketing Officer
- Tenure: 2yrs
Olaf Heyden (56yo)
Senior Vice President of Services
- Tenure: 3.2yrs
- Compensation: US$2.39m
Jon Leiken (47yo)
Senior VP
- Tenure: 0yrs
- Compensation: US$1.90m
Steve Virostek
Vice President of Investor Relations
- Tenure: 0yrs
Murat Ekinci (49yo)
Chief Information Officer
- Tenure: 2.7yrs
Ulrich Näher (54yo)
Senior Vice President of Products
- Tenure: 3.2yrs
- Compensation: US$2.37m
Lisa Radigan
Chief Ethics & Compliance Officer and VP
- Tenure: 4.9yrs
Board Members
Gary Greenfield (64yo)
Non-Executive Chairman
- Tenure: 1.8yrs
- Compensation: US$345.12k
Ellen Costello (64yo)
Independent Director
- Tenure: 1.3yrs
- Compensation: US$214.66k
Patrick Allender (72yo)
Independent Director
- Tenure: 8.5yrs
- Compensation: US$268.19k
Phil Cox (71yo)
Independent Director
- Tenure: 14.8yrs
- Compensation: US$263.42k
Bruce Besanko (60yo)
Independent Director
- Tenure: 1.1yrs
- Compensation: US$46.74k
Alex Dibelius (60yo)
Independent Director
- Tenure: 3.2yrs
- Compensation: US$250.12k
Gerrard Schmid (50yo)
President
- Tenure: 1.7yrs
- Compensation: US$7.04m
Matt Goldfarb (47yo)
Independent Director
- Tenure: 0.5yrs
Kent Stahl (56yo)
Independent Director
- Tenure: 0.5yrs
Dieter Duesedau (61yo)
Independent Director
- Tenure: 3.2yrs
- Compensation: US$255.12k
Company Information
Diebold Nixdorf, Incorporated's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Diebold Nixdorf, Incorporated
- Ticker: DBD
- Exchange: NYSE
- Founded: 1859
- Industry: Technology Hardware, Storage and Peripherals
- Sector: Tech
- Market Cap: US$729.087m
- Shares outstanding: 76.75m
- Website: https://www.dieboldnixdorf.com
Number of Employees
Location
- Diebold Nixdorf, Incorporated
- 5995 Mayfair Road
- PO Box 3077
- North Canton
- Ohio
- 44720
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| DBD | NYSE (New York Stock Exchange) | Yes | Common Shares | US | USD | Jan 1968 |
| DBD | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Jan 1968 |
| DBD | XTRA (XETRA Trading Platform) | Yes | Common Shares | DE | EUR | Jan 1968 |
| WIN | SWX (SIX Swiss Exchange) | Yes | Common Shares | CH | CHF | Jan 1968 |
Biography
Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The compa ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/22 23:34 |
| End of Day Share Price | 2019/10/22 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.